#USA #San Diego #Salus Scientific #TCT 2026 #ALARA+

Salus Scientific at TCT 2026: A New Age in Procedural Workforce Safety

Salus Scientific is excited to announce its participation in the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2026, taking place from October 31 to November 3 in San Diego. This marks the company's debut at the event where they will showcase their advanced range of technologies aimed at ensuring the safety and wellbeing of healthcare professionals who work in fluoroscopy-guided procedures. The event, known for bringing together professionals in cardiovascular therapies, is a fitting venue for the launch of Salus's cutting-edge safety solutions.

The Need for Enhanced Safety Standards

With more than 24 million fluoroscopy-guided procedures performed annually, healthcare professionals face significant risks due to cumulative exposure to scatter radiation. Traditional lead protection has been a common method of shielding; however, it comes with its own drawbacks, including musculoskeletal strain and orthopedic injuries. A survey indicated nearly 60% of interventionalists have reported injuries linked to lead protection wear. These statistics underscore the urgent need for a more comprehensive safety approach.

At the heart of the discussion around procedural workforce safety is the recently published ALARA+ Consensus Statement, which has redefined expectations regarding occupational radiation exposure. This multi-society guideline emphasizes the importance of not only addressing radiation exposure but also improving ergonomic conditions for healthcare workers.

Salus Scientific's Innovative Solutions

Todd Flohr, co-founder and CEO of Salus Scientific, stated, "For years, healthcare professionals accepted radiation exposure and the physical burden of lead protection as part of the job. The ALARA+ recommendations highlight that we must do better. Our aim is to provide solutions that not only safeguard against radiation but also alleviate the physical burden on healthcare professionals."

Salus Scientific's diverse product portfolio includes:

• - AeroShield™ Enhanced Radiation Protection System: This technology aims to significantly reduce scatter radiation exposure for the entire procedural team.
• - GLiFT™ Endoskeleton System: This innovative design transfers the weight of protective garments from the shoulders and spine to the hips and pelvis, lessening the physical strain on workers.
• - Real-time Dosimetry and Radiation Monitoring Solutions:

These tools assist healthcare professionals in tracking their radiation exposure levels and ensuring compliance with safety standards.

• - Comprehensive Radiation Protection Education Programs: These programs are intended to inform and assist healthcare workers with compliance and safety management.

These technological advancements are crucial not only for compliance but for enhancing the overall safety of healthcare providers and patients alike.

A Collaborative Future

In addition to unveiling their innovations, Salus Scientific recently entered a strategic partnership with USVetServ, facilitating access to its advanced technologies within Veterans Affairs and Department of Defense healthcare facilities. This collaboration signifies a growing recognition of the necessity for improved safety measures in all areas of healthcare.

As part of their presence at TCT 2026, Salus Scientific is committed to engaging with attendees—including physicians, healthcare leaders, and industry stakeholders—to discuss the transition from traditional safety protocols to more effective and comprehensive solutions. The goal is to foster a culture where radiation protection is viewed not merely as a compliance issue, but as an integral part of patient and workforce safety.

William Gray, M.D., an esteemed member of the Salus Scientific Advisory Board, emphasizes the importance of this conversation. He noted, "Protecting the procedural workforce means considering the entire care delivery environment. Traditional challenges concerning radiation exposure and lead protection need a re-evaluation in light of new technologies and insights."

Conclusion

As Salus Scientific prepares for TCT 2026, it stands poised to make a significant impact on how healthcare professionals perceive and manage safety in their practice. By advocating for cutting-edge technologies that address both radiation risks and physical burdens, Salus reinforces its mission that occupational hazards do not have to be an accepted part of medical careers. Instead, through continuous innovation and collaboration, Salus Scientific is paving the way for a safer future in healthcare.

For further inquiries or to learn more about their portfolio, please visit Salus Scientific's website.